Toggle Nav
Close
  • Menu
  • Setting

BFH772

Catalog No.
B6199
VEGFR2 inhibitor
Grouped product items
SizePriceStock Qty
5mg
$70.00
In stock
10mg
$115.00
In stock
25mg
$220.00
In stock
50mg
$320.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

BFH772 (CAS 890128-81-1) is a small-molecule inhibitor targeting VEGFR2 kinase, exhibiting an IC50 value of 3 nM. It selectively inhibits signaling mediated via VEGFR2, a receptor tyrosine kinase activated by VEGFs (VEGF-A, VEGF-B, VEGF-C, VEGF-D) and PlGF, crucial in angiogenesis. BFH772 displays approximately 500-fold reduced potency against related receptors FLK-1, FLT-1, and FLT-4 and about 40-fold lower efficacy against kinases such as B-RAF, RET, and TIE-2. In animal tumor models, oral administration markedly reduces tumor growth and angiogenesis. BFH772 has entered clinical studies for rosacea treatment.

Chemical Properties

StorageStore at -20°C
M.Wt439.39
Cas No.890128-81-1
FormulaC23H16F3N3O3
Solubility≥53.4 mg/mL in DMSO; ≥15.33 mg/mL in EtOH; insoluble in H2O
Chemical Name6-((6-(hydroxymethyl)pyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide
SDFDownload SDF
Canonical SMILESO=C(C1=C2C=CC(OC3=NC=NC(CO)=C3)=CC2=CC=C1)NC4=CC=CC(C(F)(F)F)=C4
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Quality Control